{"id":951299,"date":"2019-03-07T17:28:00","date_gmt":"2019-03-07T17:28:00","guid":{"rendered":"https:\/\/www.capgemini.com\/in-en\/?post_type=client-story&#038;p=951299"},"modified":"2025-03-21T08:25:31","modified_gmt":"2025-03-21T08:25:31","slug":"empowering-patients-to-continue-treatment-for-oab","status":"publish","type":"client-story","link":"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/","title":{"rendered":"Empowering Patients to Continue Treatment for OAB"},"content":{"rendered":"\n<header class=\"wp-block-cg-blocks-hero-reusable header heroReusable  \"><div class=\"header-bgs\"><picture><source srcset=\"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-8.png?w=2880&amp;quality=70 1x, https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-8.png?w=2880&amp;quality=70 2x\" media=\"(min-width: 1500px)\"\/><source srcset=\"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-8.png?w=1440&amp;quality=70 1x, https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-8.png?w=2880&amp;quality=70 2x\" media=\"(min-width: 992px)\"\/><source srcset=\"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-8.png?w=1024&amp;quality=70 1x, https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-8.png?w=1024&amp;quality=70 2x\" media=\"(min-width: 768px)\"\/><source srcset=\"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-8.png?w=768&amp;quality=70 1x, https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-8.png?w=768&amp;quality=70 2x\" media=\"(min-width: 0)\"\/><img decoding=\"async\" src=\"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-8.png\" class=\"header-img header-img-d\" alt=\"\" style=\"object-fit:cover;object-position:50% 50%\" loading=\"eager\"\/><\/picture><\/div><div class=\"heroPictureCardHeaderShape\"><\/div><div class=\"container\"><div class=\"row\"><div class=\"col-md-12\"><div class=\"box\"><div class=\"boxTagWrapper\"><div class=\"tagInfo\"><div><span class=\"box-tag\">Client Stories<\/span><\/div><\/div><\/div><div class=\"box-title\"><h1 data-maxlength=\"34\">Empowering Patients to Continue Treatment for OAB<\/h1><\/div><div class=\"inner-row-insight download-btn\"><div class=\"col-md-4 downloadFiles addPadding\"><a class=\"button-download--small\" type=\"download\" href=\"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/Empowering-Patients-to-Continue-Treatment-for-OAB-2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><span>Empowering-Patients-to-Continue-Treatment-for-OAB-2.pdf<\/span><span class=\"type\">897 KB  pdf<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/header>\n\n\n\n<section class=\"wp-block-cg-blocks-intro-para undefined section section--intro\"><div class=\"intro-para\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-1\"><nav class=\"article-social\"><ul class=\"social-nav\"><li class=\"ip-order-fb\"><a href=\"https:\/\/www.facebook.com\/sharer\/sharer.php?u=https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><i aria-hidden=\"true\" class=\"icon-fb\"><\/i><span class=\"sr-only\">Facebook<\/span><\/a><\/li><li class=\"ip-order-li\"><a href=\"https:\/\/www.linkedin.com\/sharing\/share-offsite\/?url=https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><span class=\"sr-only\">Linkedin<\/span><\/a><\/li><\/ul><\/nav><\/div><div class=\"col-12 col-md-11 col-lg-10\"><h2 class=\"intro-para-title\">THE CHALLENGE<\/h2><\/div><\/div><\/div><\/div><\/section>\n\n\n\n<section class=\"wp-block-cg-blocks-group undefined section section--article-content\"><div class=\"article-main-content\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-11 col-lg-10 offset-md-1 offset-lg-1\"><div class=\"article-text article-quote-text\">\n<p>Finding relief for OAB symptoms can be a long, frustrating journey. The majority of patients cycle through multiple oral medications without satisfactory results. 50% of patients discontinue treatment and many give up on treatment entirely. Patients are often not aware of other treatment options. Hence, patients tend to \u201csettle\u201d for just coping with their symptoms.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-our-solution\">OUR SOLUTION<\/h3>\n\n\n\n<p><a href=\"https:\/\/www.capgemini.com\/in-en\/about-us\/who-we-are\/our-brands\/capgemini-invent\/\">Capgemini Invent<\/a> approached this challenge by creating a multi-platform, unbranded campaign that was designed to engage, motivate, and educate OAB sufferers about their treatment options.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-the-impact\">THE IMPACT<\/h3>\n\n\n\n<p>Our solution proved successful in the following ways:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Averaged 140,568 website visits per week<\/li>\n\n\n\n<li>Averaged 1,758 \u201cFind a Specialist\u201d searches per week<\/li>\n\n\n\n<li>Nearly 700 registrants in the CRM program<\/li>\n\n\n\n<li>48% above average industry open rate for emails<\/li>\n\n\n\n<li>Double the average industry click-through rate<\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":103,"featured_media":951302,"template":"","meta":{"cg_dt_proposed_to":[],"cg_seo_hreflang_relations":"[]","cg_seo_canonical_relation":"","cg_seo_hreflang_x_default_relation":"{\"uuid\":\"1eee39b4-7b98-4638-9811-aeb9e3e32543\",\"blogId\":\"\",\"domain\":\"\",\"sitePath\":\"\",\"postLink\":\"\",\"postId\":null,\"isSaved\":true,\"isCrossLink\":false,\"hasCrossLink\":false}","cg_dt_approved_content":true,"cg_dt_mandatory_content":false,"cg_dt_notes":"","cg_dg_source_changed":false,"cg_dt_link_disabled":false,"footnotes":"","client_logo_id":0,"client_logo_url":"","primary_term":"","featured_focal_points":""},"tags":[],"brand":[],"service":[],"industry":[],"partners":[],"country":[],"content-group":[],"class_list":["post-951299","client-story","type-client-story","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.8 (Yoast SEO v22.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Empowering Patients to Continue Treatment for OAB - Capgemini India<\/title>\n<meta name=\"description\" content=\"Client StoriesEmpowering Patients to Continue Treatment for OABEmpowering-Patients-to-Continue-Treatment-for-OAB-2.pdf897 KB pdf FacebookLinkedinTHE\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Empowering Patients to Continue Treatment for OAB\" \/>\n<meta property=\"og:description\" content=\"Client StoriesEmpowering Patients to Continue Treatment for OABEmpowering-Patients-to-Continue-Treatment-for-OAB-2.pdf897 KB pdf FacebookLinkedinTHE\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/\" \/>\n<meta property=\"og:site_name\" content=\"Capgemini India\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-21T08:25:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-9.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2250\" \/>\n\t<meta property=\"og:image:height\" content=\"1365\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/\",\"url\":\"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/\",\"name\":\"Empowering Patients to Continue Treatment for OAB - Capgemini India\",\"isPartOf\":{\"@id\":\"https:\/\/www.capgemini.com\/in-en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-9.png\",\"datePublished\":\"2019-03-07T17:28:00+00:00\",\"dateModified\":\"2025-03-21T08:25:31+00:00\",\"description\":\"Client StoriesEmpowering Patients to Continue Treatment for OABEmpowering-Patients-to-Continue-Treatment-for-OAB-2.pdf897 KB pdf FacebookLinkedinTHE\",\"breadcrumb\":{\"@id\":\"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/#breadcrumb\"},\"inLanguage\":\"en-IN\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-IN\",\"@id\":\"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/#primaryimage\",\"url\":\"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-9.png\",\"contentUrl\":\"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-9.png\",\"width\":2250,\"height\":1365},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.capgemini.com\/in-en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Client Stories\",\"item\":\"https:\/\/www.capgemini.com\/in-en\/client-story\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Empowering Patients to Continue Treatment for OAB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.capgemini.com\/in-en\/#website\",\"url\":\"https:\/\/www.capgemini.com\/in-en\/\",\"name\":\"Capgemini India\",\"description\":\"Capgemini\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.capgemini.com\/in-en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-IN\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Empowering Patients to Continue Treatment for OAB - Capgemini India","description":"Client StoriesEmpowering Patients to Continue Treatment for OABEmpowering-Patients-to-Continue-Treatment-for-OAB-2.pdf897 KB pdf FacebookLinkedinTHE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/","og_locale":"en_US","og_type":"article","og_title":"Empowering Patients to Continue Treatment for OAB","og_description":"Client StoriesEmpowering Patients to Continue Treatment for OABEmpowering-Patients-to-Continue-Treatment-for-OAB-2.pdf897 KB pdf FacebookLinkedinTHE","og_url":"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/","og_site_name":"Capgemini India","article_modified_time":"2025-03-21T08:25:31+00:00","og_image":[{"width":2250,"height":1365,"url":"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-9.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/","url":"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/","name":"Empowering Patients to Continue Treatment for OAB - Capgemini India","isPartOf":{"@id":"https:\/\/www.capgemini.com\/in-en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/#primaryimage"},"image":{"@id":"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/#primaryimage"},"thumbnailUrl":"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-9.png","datePublished":"2019-03-07T17:28:00+00:00","dateModified":"2025-03-21T08:25:31+00:00","description":"Client StoriesEmpowering Patients to Continue Treatment for OABEmpowering-Patients-to-Continue-Treatment-for-OAB-2.pdf897 KB pdf FacebookLinkedinTHE","breadcrumb":{"@id":"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/#breadcrumb"},"inLanguage":"en-IN","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/"]}]},{"@type":"ImageObject","inLanguage":"en-IN","@id":"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/#primaryimage","url":"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-9.png","contentUrl":"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-9.png","width":2250,"height":1365},{"@type":"BreadcrumbList","@id":"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.capgemini.com\/in-en\/"},{"@type":"ListItem","position":2,"name":"Client Stories","item":"https:\/\/www.capgemini.com\/in-en\/client-story\/"},{"@type":"ListItem","position":3,"name":"Empowering Patients to Continue Treatment for OAB"}]},{"@type":"WebSite","@id":"https:\/\/www.capgemini.com\/in-en\/#website","url":"https:\/\/www.capgemini.com\/in-en\/","name":"Capgemini India","description":"Capgemini","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.capgemini.com\/in-en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-IN"}]}},"brand_term":[],"parsely":{"version":"1.1.0","canonical_url":"https:\/\/capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/","smart_links":{"inbound":0,"outbound":0},"traffic_boost_suggestions_count":0,"meta":{"@context":"https:\/\/schema.org","@type":"NewsArticle","headline":"Empowering Patients to Continue Treatment for OAB","url":"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/","mainEntityOfPage":{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/"},"thumbnailUrl":"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-9.png?w=150&h=150&crop=1","image":{"@type":"ImageObject","url":"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-9.png"},"articleSection":"Uncategorized","author":[],"creator":[],"publisher":{"@type":"Organization","name":"Capgemini India","logo":""},"keywords":[],"dateCreated":"2019-03-07T17:28:00Z","datePublished":"2019-03-07T17:28:00Z","dateModified":"2025-03-21T08:25:31Z"},"rendered":"<meta name=\"parsely-title\" content=\"Empowering Patients to Continue Treatment for OAB\" \/>\n<meta name=\"parsely-link\" content=\"https:\/\/www.capgemini.com\/in-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/\" \/>\n<meta name=\"parsely-type\" content=\"post\" \/>\n<meta name=\"parsely-image-url\" content=\"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-9.png?w=150&amp;h=150&amp;crop=1\" \/>\n<meta name=\"parsely-pub-date\" content=\"2019-03-07T17:28:00Z\" \/>\n<meta name=\"parsely-section\" content=\"Uncategorized\" \/>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/capgemini.com\/p.js"},"archive_status":false,"featured_image_src":"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-9.png","featured_image_alt":"","jetpack_sharing_enabled":true,"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Capgemini India","distributor_original_site_url":"https:\/\/www.capgemini.com\/in-en","push-errors":false,"featured_image_url":"https:\/\/www.capgemini.com\/in-en\/wp-content\/uploads\/sites\/18\/2022\/05\/invent-hero-9.png","_links":{"self":[{"href":"https:\/\/www.capgemini.com\/in-en\/wp-json\/wp\/v2\/client-story\/951299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.capgemini.com\/in-en\/wp-json\/wp\/v2\/client-story"}],"about":[{"href":"https:\/\/www.capgemini.com\/in-en\/wp-json\/wp\/v2\/types\/client-story"}],"author":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/in-en\/wp-json\/wp\/v2\/users\/103"}],"version-history":[{"count":6,"href":"https:\/\/www.capgemini.com\/in-en\/wp-json\/wp\/v2\/client-story\/951299\/revisions"}],"predecessor-version":[{"id":1144461,"href":"https:\/\/www.capgemini.com\/in-en\/wp-json\/wp\/v2\/client-story\/951299\/revisions\/1144461"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/in-en\/wp-json\/wp\/v2\/media\/951302"}],"wp:attachment":[{"href":"https:\/\/www.capgemini.com\/in-en\/wp-json\/wp\/v2\/media?parent=951299"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.capgemini.com\/in-en\/wp-json\/wp\/v2\/tags?post=951299"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/www.capgemini.com\/in-en\/wp-json\/wp\/v2\/brand?post=951299"},{"taxonomy":"service","embeddable":true,"href":"https:\/\/www.capgemini.com\/in-en\/wp-json\/wp\/v2\/service?post=951299"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.capgemini.com\/in-en\/wp-json\/wp\/v2\/industry?post=951299"},{"taxonomy":"partners","embeddable":true,"href":"https:\/\/www.capgemini.com\/in-en\/wp-json\/wp\/v2\/partners?post=951299"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/www.capgemini.com\/in-en\/wp-json\/wp\/v2\/country?post=951299"},{"taxonomy":"content-group","embeddable":true,"href":"https:\/\/www.capgemini.com\/in-en\/wp-json\/wp\/v2\/content-group?post=951299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}